Regulatory B cells in transplantation: roadmaps to clinic

Regulatory B cells in transplantation: roadmaps to clinic

Over the last two decades, an additional and important role for B cells has been established in immune regulation. Preclinical studies demonstrate that regulatory B cells (Breg) can prolong allograft survival in animal models and induce regulatory T cells. Operationally tolerant human kidney transpl...

Bibliografski detalji
Glavni autori:	Beckett, J, Hester, J, Issa, F, Shankar, S
Format:	Journal article
Jezik:	English
Izdano:	Wiley 2020

Slični predmeti

Towards regulatory cellular therapies in solid organ transplantation
od: Bottomley, MJ, i dr.
Izdano: (2021)

Ex vivo-expanded human CD19+TIM-1+ regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1/STAT3 axis
od: Shankar, S, i dr.
Izdano: (2022)

Chimeric antigen receptors and regulatory T cells: the potential for HLA-specific immunosuppression in transplantation
od: Wright, S, i dr.
Izdano: (2021)

Ex vivo-expanded human CD19+TIM-1+ regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1/STAT3 axis
od: S. Shankar, i dr.
Izdano: (2022-06-01)

Regulatory immune cells in transplantation.
od: Wood, K, i dr.
Izdano: (2012)

IL‐33 drives the production of mouse regulatory T cells with enhanced in vivo suppressive activity in skin transplantation
od: Kawai, K, i dr.
Izdano: (2020)

Chimeric Antigen Receptors and Regulatory T Cells: The Potential for HLA-Specific Immunosuppression in Transplantation
od: Sabrina Wright, i dr.
Izdano: (2022-03-01)

Regulatory T cells for tolerance
od: Kawai, K, i dr.
Izdano: (2017)

Regulatory T-cell therapy approaches
od: McCallion, O, i dr.
Izdano: (2022)

Regulatory B-Cells in Transplantation
od: David San Segundo, i dr.
Izdano: (2013-11-01)

CD4+ regulatory T cells in solid organ transplantation.
od: Issa, F, i dr.
Izdano: (2010)

Closing the gap: a roadmap to single‐cell regulatory genomics
od: Julie Carnesecchi, i dr.
Izdano: (2020-05-01)

Deciphering the contribution of γδ T cells to outcomes in transplantation
od: McCallion, O, i dr.
Izdano: (2018)

ESOT Roadmap for Advanced Therapy Medicinal Products in Transplantation: Navigating Regulatory Challenges to Enhance Access and Care
od: Ekaterine Berishvili, i dr.
Izdano: (2024-10-01)

Transplanters drive CARs to the clinic by brewing ICE-T: the Moffitt roadmap
od: Frederick L. Locke, i dr.
Izdano: (2017-07-01)

Induction of transplantation tolerance through regulatory cells: from mice to men.
od: Ferrer, I, i dr.
Izdano: (2014)

ESOT Roadmap for Advanced Therapy Medicinal Products in Transplantation: Navigating Regulatory Challenges to Enhance Access and Care
od: Berishvili, E, i dr.
Izdano: (2024)

The potential role for regulatory T-cell therapy in vascularized composite allograft transplantation.
od: Issa, F, i dr.
Izdano: (2014)

Regulatory B Cell Therapy in Kidney Transplantation
od: Sergio G. Garcia, i dr.
Izdano: (2021-12-01)

Ex vivo-expanded human CD19+CD73-CD25+CD71+TIM-1+ B regulatory cells can prolong allograft survival in a humanized mouse model of skin transplantation and are dependent on TIM1-mediated regulation of STAT3 signaling
od: Shankar, S, i dr.
Izdano: (2018)

Distinct metabolic pathways mediate regulatory T cell differentiation and function
od: Hashimoto, H, i dr.
Izdano: (2020)

Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients
od: Brook, MO, i dr.
Izdano: (2022)

Homing of regulatory T cells to human skin is important for the prevention of alloimmune-mediated pathology in an in vivo cellular therapy model.
od: Issa, F, i dr.
Izdano: (2012)

Access to medicines for rare diseases: A European regulatory roadmap for academia
od: Noa Rosenberg, i dr.
Izdano: (2023-02-01)

Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo.
od: Hester, J, i dr.
Izdano: (2012)

Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo.
od: Hester, J, i dr.
Izdano: (2012)

Live donor kidney transplantation. Situation analysis and roadmap
od: María de la Oliva Valentín, i dr.
Izdano: (2022-01-01)

Editorial: regulatory T cells
od: Issa, F, i dr.
Izdano: (2022)

Regulatory T cells in transplantation: transferring mouse studies to the clinic.
od: Long, E, i dr.
Izdano: (2009)

Regulatory T cells in transplantation.
od: Wood, K
Izdano: (2011)

Regulatory cells in transplantation.
od: Wood, K, i dr.
Izdano: (2003)

Regulatory T cells in transplantation
od: Wood, K
Izdano: (2011)

Regulatory T cells in transplantation.
od: Waldmann, H, i dr.
Izdano: (2006)

Regulatory T cells in transplantation.
od: Karim, M, i dr.
Izdano: (2002)

Regulatory B cells: an exciting target for future therapeutics in transplantation
od: Alexandre eNouël, i dr.
Izdano: (2014-01-01)

Tissue targeted regulatory T cell therapy prevents human skin allograft rejection in a humanised mouse model
od: Issa, F, i dr.
Izdano: (2013)

Stem Cells for Cartilage Regeneration: A Roadmap to the Clinic
od: Celeste Scotti, i dr.
Izdano: (2018-01-01)

Clinical research in Africa And Middle East: roadmap for reform and harmonisation of the regulatory framework and sustainable capacity development
od: Faiez Zannad, i dr.
Izdano: (2019-12-01)

Modulation of CD27/CD70 co-stimulatory pathway may allow for the generation of a more potent human regulatory T cell product for cell therapy
od: Arroyo Hornero, R, i dr.
Izdano: (2017)

Roadmap for Clinical Research Work
od: María Florencia Grande Ratti, i dr.
Izdano: (2023-06-01)